Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study (Q42989003)
scientific article published on December 2004
Language:
Current Data About Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study
(P31) (Q13442814)
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

(P304) 1260-1265
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

(P407) (Q1860)

(P433) 6
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

(P478) 40
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

(P577) Wednesday, December 1, 2004
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

(P921) (Q7160835)
(P887)

(P1433) (Q15724398)
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

(P1476) "Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study" (language: en)
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

(P2093) Olav Dalgard
(P1545) 1
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

Kristian Bjøro
(P1545) 2
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

Kjell Block Hellum
(P1545) 3
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

Bjørn Myrvang
(P1545) 4
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

Ståle Ritland
(P1545) 5
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

Kjell Skaug
(P1545) 6
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

Nils Raknerud
(P1545) 7
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

Helge Bell
(P1545) 8
(P248)
(P698) 15558712
(P813) Sunday, November 12, 2017

(P2860) (Q27860949)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q27860901)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q52010912)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q44038693)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q50582465)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q42990634)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q43029666)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q42992189)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q33809452)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q57205742)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Sunday, January 21, 2018

(Q29547886)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Thursday, January 7, 2021
(P887)

(Q29619627)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Thursday, January 7, 2021
(P887)

(Q77569187)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20467
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on December 2004

External Links
(P356) 10.1002/HEP.20467
(P698) 15558712